logo inner

VP, Chemistry

CareDxBrisbane, Australia | California, United StatesOnsite
This job is no longer open

Headquartered in Brisbane, CA, CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
 We are seeking a highly motivated, critical, and creative individual to join the CareDx R&D team. This is an exciting opportunity to be part of a growing, dynamic, and collaborative R&D team delivering cutting-edge technology directly to clinicians. The primary function of this position will be to drive development of innovative diagnostic solutions for transplant recipients through a variety of technologies for analyte measurement. The ideal candidate will be able to develop new reagents to improve testing processes, working closely with cross functional teams including product development, bioinformatics, biostatistics, data science, lab operations.

Responsibilities:


  • Provide deep technical expertise to guide development of novel reagents and methods.
  • Lead a team developing regents to enable measurement of a variety of analytes (DNA, RNA, proteins) in standard diagnostic matrices such as blood and urine.  
  • Manage scientists and research associates with expertise in reagents for high sensitivity product development using multiple technologies. 
  • Guide the design and execution of high-value reagent development  
  • Liaise with relevant stakeholders in product development, regulatory, and commercial to coordinate and align activities 
  • Build strong partnerships with collaborators by identifying potential academic and industrial partners to accelerate CareDx programs
  • Drive projects; ensure that budget, timeline, staffing and other corporate/program objectives and goals are met
  • Identify areas for assay improvement and propose and implement solutions
  • Provide technical leadership, mentorship, and development for junior staff to form highly productive team members
  • Ensure all work is performed and documented in compliance with applicable regulatory and quality practices
  • Other duties as assigned

Qualifications:


  • Ph.D. in chemistry, biochemistry, or a related discipline with 15+ years of experience, at least 10 years of industry experience, and 5 years of experience managing teams.
  • Demonstrated leadership in reagent development for clinical diagnostics, ideally with Design Control experience
  • Proven scientific leadership and management of high performing individuals and cross functional teams – direct experience managing people required
  • Ability to collect requirements, plan activities and prioritize activities/assignments to supporting team members
  • Able to identify risk and provide recommendations for risk mitigation in area of responsibility and at project level.

Additional Details:


Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.Our competitive Total Rewards package includes:

  • Competitive base salary and incentive compensation
  • Health and welfare benefits including a gym reimbursement program
  • 401(k) savings plan match
  • Employee Stock Purchase Plan
  • Pre-tax commuter benefits
  • And more!

In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.CareDx, Inc. is an Equal Opportunity Employer and participate in E-Verify program.By proceeding with our application and submitting your information, you acknowledge that you have read our U.S.

Personnel Privacy Notice and consent to receive email communication from CareDx.******** We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.#LI-Onsite

This job is no longer open

Life at CareDx

CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
Thrive Here & What We Value1. Focus on improving the lives of organ transplant patients worldwide2. Taking great care of our people, so they take even greater care of our patients3. CareDx offers products, testing services, and digital healthcare solutions along the pre and post-transplant patient journey4. CareDx is the leading provider of genomics-based information for transplant patients5. Competitive Total Rewards package including: Competitive base salary and incentive compensation, Health and welfayer benefits, 401(k) savings plan match, Employee Stock Purchase Plan, Pretax commuter benefits
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024